Dechra Pharmaceuticals announces Lawson Macartney to its Board as upcoming Non-Executive Director

– UK, Northwich – Dechra Pharmaceuticals plc (LSE: DPH) is pleased to announce that Lawson Macartney has been appointed to the Board as Non-Executive Director with effect from 1 December 2016.

Dr Macartney, a qualified veterinarian, is Chairman of Viking Therapeutics Inc., a developer of novel therapeutics for patients suffering from metabolic and endocrine disorders, and an adviser to several biopharmaceutical companies and life science consultancies. Prior to this, Dr Macartney was President and CEO of Ambrx Inc., Senior Vice President and Head of Emerging Business at Shire AG, and held various senior, global commercial, sales, marketing and strategy roles at GlaxoSmithKline plc.

Ian Page, Chief Executive Officer, Dechra Pharmaceuticals said: “We are delighted to welcome Lawson to the Board and we look forward to working with him. Lawson’s 30 years of experience gained in the global pharmaceutical industry will bring further knowledge and expertise of product development to the Board.”

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and relates products business. Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra’s business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.

For more information : http://www.dechra.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here, the original post =>